Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
118.21
-1.72 (-1.43%)
Nov 9, 2026, 4:00 PM EST - Market closed
Haemonetics Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
| 5,383 | 2,511 | 3,175 | 4,335 | 4,175 | 3,263 | |
Market Cap Growth | 68.22% | -20.89% | -26.76% | 3.83% | 27.92% | -42.69% |
Enterprise Value | 6,244 | 3,373 | 4,145 | 5,011 | 4,717 | 3,809 |
Last Close Price | 118.21 | 54.04 | 63.19 | 85.35 | 82.75 | 63.85 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
PE Ratio | 52.81 | 25.81 | 18.93 | 36.87 | 36.17 | 75.24 |
Forward PE | 20.11 | 10.46 | 13.21 | 20.49 | 25.45 | 23.82 |
PS Ratio | 3.89 | 1.88 | 2.33 | 3.31 | 3.57 | 3.29 |
PB Ratio | 5.99 | 3.15 | 3.87 | 4.51 | 5.10 | 4.36 |
P/TBV Ratio | - | - | - | - | 54.93 | - |
P/FCF Ratio | 18.05 | 9.64 | 22.29 | 30.18 | 51.08 | 43.08 |
P/OCF Ratio | 15.61 | 8.57 | 17.47 | 23.85 | 15.29 | 18.95 |
PEG Ratio | 2.14 | 0.96 | 1.00 | 1.39 | 2.42 | 1.36 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
EV/Sales Ratio | 4.52 | 2.53 | 3.05 | 3.83 | 4.04 | 3.84 |
EV/EBITDA Ratio | 17.16 | 9.44 | 11.65 | 17.04 | 18.72 | 19.87 |
EV/EBIT Ratio | 23.98 | 13.41 | 16.78 | 24.38 | 28.21 | 36.22 |
EV/FCF Ratio | 20.94 | 12.95 | 29.10 | 34.89 | 57.71 | 50.28 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
Debt / Equity Ratio | 1.25 | 1.60 | 1.56 | 0.91 | 1.02 | 1.12 |
Debt / EBITDA Ratio | 3.00 | 3.47 | 3.49 | 2.87 | 3.28 | 4.14 |
Debt / FCF Ratio | 3.77 | 4.89 | 9.01 | 6.08 | 10.16 | 11.07 |
Net Debt / Equity Ratio | 0.96 | 1.29 | 1.19 | 0.72 | 0.67 | 0.77 |
Net Debt / EBITDA Ratio | 2.37 | 2.88 | 2.74 | 2.36 | 2.16 | 3.02 |
Net Debt / FCF Ratio | 2.89 | 3.95 | 6.85 | 4.83 | 6.67 | 7.64 |
Asset Turnover | 0.57 | 0.55 | 0.59 | 0.63 | 0.62 | 0.54 |
Inventory Turnover | 1.74 | 1.61 | 1.71 | 2.08 | 1.98 | 1.50 |
Quick Ratio | 1.62 | 1.64 | 0.88 | 1.29 | 1.85 | 0.95 |
Current Ratio | 2.84 | 2.95 | 1.62 | 2.56 | 3.06 | 1.71 |
Return on Equity (ROE) | 11.89% | 12.03% | 18.83% | 13.22% | 14.72% | 5.86% |
Return on Assets (ROA) | 6.71% | 6.49% | 6.65% | 6.22% | 5.51% | 3.57% |
Return on Invested Capital (ROIC) | 10.75% | 10.56% | 11.33% | 10.55% | 10.14% | 5.40% |
Return on Capital Employed (ROCE) | 12.30% | 11.90% | 13.20% | 10.80% | 9.90% | 7.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
Earnings Yield | 1.89% | 3.88% | 5.28% | 2.71% | 2.76% | 1.33% |
FCF Yield | 5.54% | 10.37% | 4.49% | 3.31% | 1.96% | 2.32% |
Buyback Yield / Dilution | 5.39% | 6.65% | 1.30% | 0.04% | -0.13% | -0.12% |